Wednesday 20 October 2010

Albufuse

Half-life extension through albumin fusion technology

A simple, single step expression platform for the production of proteins with extended half-life. Avoids post-production costs associated with chemical processing such as PEGylation.

Combine albumin fusion albufuse with our yeast expression technology and cGMP/Q7-manufacturing services to maximize the benefits of working with us.

Key benefits

  • Increased half-life of the active molecule, resulting in:
    • Less frequent administration
    • Increased bioavailability therefore lowered dosage
  • Fewer side effects with improved tolerance
  • Competitive production costs
  • Specific albumin fusion binding matrices available for improved downstream purification
  • Animal-free
  • Genetically fused.

Application areas

No comments:

Post a Comment